Pfizer introduces 12-week paternity leave policy

Fathers are entitled to take leave in four tranches under the new policy that came into effect on 1 January 2023.
By: | January 9, 2023

In an effort to foster diversity and inclusion, biopharmaceutical giant Pfizer has announced a 12-week paternity leave policy, where both biologically related or adoptive fathers can take leave over a two-year period in four tranches.

Each tranche may be taken for a minimum of two weeks and a maximum of six weeks. Should the need arise, each employee will also be allowed to take additional leaves, including causal leave, elective holidays, and wellness days, as permitted by the organisation’s leave policy, reported Business Standard.

READ: India considers paternity leave extension

Shilpi Singh, Director People Experience, Pfizer India, said, “We believe the future of a progressive workspace will be defined by practices that harness a people-first approach.”

“The 12-week paternity leave policy will most certainly enable our male colleagues and their partners to cherish the experience and joyful moments of parenthood. A progressive policy of this nature is our endeavour to harness the power of equity at the workplace and enable both men and women to invest equal time in essaying their roles and responsibilities as a parent.”